Evidence map›Paper›PMID 37923755›Full record

ArticleScientific reports2023

Successful fat-only whole breast reconstruction using cultured mature adipocytes and conditioned medium containing MCP-1.

Hiroko Yanaga, Mika Koga, Hiromichi Nishina, Yoshio Tanaka, Katsu Yanaga

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hiroko YanagaYanaga Clinic and Tissue Culture Laboratory, 1-2-12 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan. force@yanaga-cl.com.
Mika KogaYanaga Clinic and Tissue Culture Laboratory, 1-2-12 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan.
Hiromichi NishinaYanaga Clinic and Tissue Culture Laboratory, 1-2-12 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan.
Yoshio TanakaDepartment of Plastic and Reconstructive Surgery, Faculty of Medicine/Graduate School of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kida-gun, Kagawa, 761-0793, Japan.
Katsu YanagaYanaga Clinic and Tissue Culture Laboratory, 1-2-12 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan.
Kagawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A mastectomy is a curative treatment for breast cancer. It causes breast and soft tissue deficits, resulting in a chest with poor vascularity. Autologous tissue breast reconstruction is commonly associated with donor site morbidity. Breast implants are another reconstruction alternative, but they are associated with infection, rupture, and the need for replacement. Autologous aspirated fat grafting has appeared as an ideal breast reconstruction method, but low graft viability and high resorption remain as the main shortcomings. We developed a novel method for fat-only grafts using cultured mature adipocytes (CMAs) mixed with their condition medium. Twenty-five mastectomy patients, aged 32-72 years, received a mixed grafting of CMAs, MCP1-containing condition medium, and fat grafts for total breast reconstruction. In follow-up periods of 24-75 months, MRI analysis showed full thickness fat-engraftment. The cell proliferation marker Ki67 was negative in post-transplant biopsy specimens from all patients. Aesthetic full breast morphology was achieved, patient satisfaction was evaluated 1 year and 3-6 years after surgery. All grafts were confirmed safe, demonstrating high reliability and long-term sustainability.

Indexed as

Breast NeoplasmsMammaplastyAdipocytesAdipose TissueAdultAgedCulture Media, ConditionedFemaleHumansMastectomyMiddle AgedReproducibility of ResultsRetrospective StudiesTransplantation, AutologousTreatment OutcomeCulture Media, Conditioned

Identifiers

PMID37923755
PMCPMC10624668
OpenAlexW4388292499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.